immunogen press releases：AbbVie Completes Acquisition of ImmunoGen
AbbVie Completes Acquisition of ImmunoGen
2024年2月12日—NORTHCHICAGO,Ill.,Feb.12,2024/PRNewswire/--AbbVie(NYSE:ABBV)announcedtodaythatithascompleteditsacquisitionofImmunoGen( ...。其他文章還包含有：「AbbVieCompletesAcquisitionofImmunoGen」、「AbbVietoAcquireImmunoGen」、「IMGNImmunoGen」、「ImmunogenInc(IMU.SG)LatestPressReleases&...」、「ImmunoGen」、「PressReleases」
查看更多 離開網站
AbbVie Completes Acquisition of ImmunoGen
https://news.abbvie.com
These press releases remain on AbbVie's website for historical purposes only. AbbVie assumes no duty to update the information to reflect ...
AbbVie to Acquire ImmunoGen
https://investor.immunogen.com
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio.
IMGN ImmunoGen
https://seekingalpha.com
A high-level overview of ImmunoGen, Inc. (IMGN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, ...
Immunogen Inc (IMU.SG) Latest Press Releases & ...
https://finance.yahoo.com
Get the latest Immunogen Inc (IMU.SG) stock news and headlines to help you in your trading and investing decisions.
ImmunoGen
http://investor.immunogen.com
ImmunoGen is now part of AbbVie. Together we will be working to make a ... Press Releases. Feb 12, 2024. AbbVie Completes Acquisition of ImmunoGen. Read ...
Press Releases
https://investor.immunogen.com
Press Releases ; Toggle Summary November 30, 2023, AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), ...